 Home > Biochemistry News > Biotechnology News > A breakthrough in stem cell transplantation therapy for the treatment of type 1 diabetes

A breakthrough in stem cell transplantation therapy for the treatment of type 1 diabetes

 Last Update: 2021-09-07
 Source: Internet
 Author: User

Tags

gerson therapy documentary

dario diabetes

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 25, 2021, ViaCyte announced that in patients with type 1 diabetes (T1D), its in-study stem cell-derived islet cell replacement therapy PEC Direct (VC-02) has obtained positive preliminary clinical results

ViaCyte develops PEC series of therapies by differentiating pluripotent stem cells into pancreatic islet progenitor cells

▲PEC-Direct therapy for high-risk type 1 diabetes patients (picture source: ViaCyte official website)

In the study, preliminary data from the first patient 9 months after implantation of PEC-Direct showed that at the 39th week, the biomarker for evaluating the production of insulin by functional pancreatic β-cells-the maximum concentration of C-peptide after blood glucose stimulation was changed from 0.

"ViaCyte's cell replacement therapy has promising prospects

Reference materials:

[1] ViaCyte Reports Compelling Preliminary Clinical Data from Islet Cell Replacement Therapy for Patients with Type 1 Diabetes.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.